Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 30 Sep 2024

Potential tumor-specific antigens and immune landscapes identification for mRNA vaccine in thyroid cancer

in Cancer Molecular Targets and Therapeutics

Xiaoning Wang
Guixin Wang
Qiaoqiao Xu
Yingxi Li
Wenbin Song
Zhaoyi Liu
Yao Tian
Li Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1480028

1,205 views

Editorial

Published on 30 Sep 2024

Editorial: Multimodality therapy for older cancer patients

in Cancer Molecular Targets and Therapeutics

Nam P. Nguyen
Mohammad Mohammadianpanah
Meritxell Arenas
Vincent Vinh-Hung

Frontiers in Oncology

doi 10.3389/fonc.2024.1487783

374 views

Review

Published on 30 Sep 2024

Applications of cerebrospinal fluid circulating tumor cells and circulating tumor-derived DNA in diagnosis, prognosis, and personalized treatment of CNS metastases

in Cancer Molecular Targets and Therapeutics

Elena Pentsova

Frontiers in Oncology

doi 10.3389/fonc.2024.1409383

852 views

Case Report

Published on 26 Sep 2024

Case report: Tenosynovial giant cell tumor

in Cancer Molecular Targets and Therapeutics

Anke Fähnrich
Zhala Gasimova
Yamil Maluje
Fabian Ott
Helen Sievert
Stephanie Fliedner
Niklas Reimer
Axel Künstner
Niklas Gebauer
Maxim Kebenko

Frontiers in Oncology

doi 10.3389/fonc.2024.1445427

1,390 views

Original Research

Published on 19 Sep 2024

Identification of potential biomarkers for lung adenocarcinoma: a study based on bioinformatics analysis combined with validation experiments

in Cancer Molecular Targets and Therapeutics

Chuchu Zhang
Ying Liu
Yingdong Lu
Zehui Chen
Yi Liu
Qiyuan Mao
Shengchuan Bao
Ge Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1425895

1,459 views

Mini Review

Published on 17 Sep 2024

Bridging the gap: advancing cancer cell culture to reveal key metabolic targets

in Cancer Molecular Targets and Therapeutics

Marjolein M. G. Kes
Celia R. Berkers
Jarno Drost

Frontiers in Oncology

doi 10.3389/fonc.2024.1480613

1,275 views

Review

Published on 13 Sep 2024

Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance

in Cancer Molecular Targets and Therapeutics

Fatemeh Yazarlou
Ivan Martinez
Leonard Lipovich

Frontiers in Oncology

doi 10.3389/fonc.2024.1437542

2,773 views

Original Research

Published on 13 Sep 2024

Cleft lip and palate transmembrane protein 1-like is a putative regulator of tumorigenesis and sensitization of cervical cancer cells to cisplatin

in Cancer Molecular Targets and Therapeutics

Weipeng Liu
Fengdan Huang
Yueting Yao
Yan Liang
Zhiling Yan
Lili Guo
Xinwen Zhang
Li Shi
Yufeng Yao

Frontiers in Oncology

doi 10.3389/fonc.2024.1440906

991 views

Original Research

Published on 12 Sep 2024

USP7 regulates growth and maintains the stemness of p53-mutant colorectal cancer cells via stabilizing of mutant p53

in Cancer Molecular Targets and Therapeutics

Xue Li
Jie Pan
Pengcheng Zheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1427663

761 views

Mini Review

Published on 12 Sep 2024

ABHD5 as a friend or an enemy in cancer biology?

in Cancer Molecular Targets and Therapeutics

Jianya Cai
Hongwei Cheng
Shuangta Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1447509

1,062 views

Original Research

Published on 09 Sep 2024

Overexpression of serum HMGB1 and IDO in esophageal squamous cell carcinoma patients: potential clinical auxiliary diagnostic markers and immunotherapeutic targets

in Cancer Molecular Targets and Therapeutics

Wenxuan Cui
Yinghao Niu
Xueyuan Zhang
Beixuan Huang
Xiaoya Shang
Wei Zhao
Xi Yan
Yunqiang Mi

Frontiers in Oncology

doi 10.3389/fonc.2024.1452282

955 views

Editorial

Published on 06 Sep 2024

Editorial: Theranostics as a driving force in nuclear medicine

in Cancer Molecular Targets and Therapeutics

Steven P. Rowe
Rudolf A. Werner
Sangeeta Ray Banerjee

Frontiers in Oncology

doi 10.3389/fonc.2024.1468357

657 views

Case Report

Published on 03 Sep 2024

Case report: Male genital system, soft tissue and myocardial metastases in a patient with exon 11-mutated GIST of unknown origin

in Cancer Molecular Targets and Therapeutics

Michele Rota
Federico Sganzerla
Michele Zuffante
Andrea Mafficini
Michele Pavarana
Michele Milella

Frontiers in Oncology

doi 10.3389/fonc.2024.1450889

702 views

Review

Accepted on 02 Sep 2024

Therapies targeting triple-negative breast cancer： A perspective on anti-FGFR

in Cancer Molecular Targets and Therapeutics

Jinhao Chen
Chunyu Cao
Hongyan Wu
Qianru Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1415820

Original Research

Published on 30 Aug 2024

Radiosynthesis and in-vitro identification of a molecular probe 131I-FAPI targeting cancer-associated fibroblasts

in Cancer Molecular Targets and Therapeutics

Yaxin Tian
Yanghongyan Jiang
Ping Ma
Xiaowei Ma
Liang Du
Fengkui Wang
Xiaodong Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1442601

1,096 views

Review

Published on 26 Aug 2024

Targeted anti-angiogenesis therapy for advanced osteosarcoma

in Cancer Molecular Targets and Therapeutics

Qiao Zhang
Yuxuan Xia
LiYuan Wang
Yang Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1413213

1,296 views

Navigation group

Articles

Potential tumor-specific antigens and immune landscapes identification for mRNA vaccine in thyroid cancer

Editorial: Multimodality therapy for older cancer patients

Applications of cerebrospinal fluid circulating tumor cells and circulating tumor-derived DNA in diagnosis, prognosis, and personalized treatment of CNS metastases

Case report: Tenosynovial giant cell tumor

Identification of potential biomarkers for lung adenocarcinoma: a study based on bioinformatics analysis combined with validation experiments

Bridging the gap: advancing cancer cell culture to reveal key metabolic targets

Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance

Cleft lip and palate transmembrane protein 1-like is a putative regulator of tumorigenesis and sensitization of cervical cancer cells to cisplatin

USP7 regulates growth and maintains the stemness of p53-mutant colorectal cancer cells via stabilizing of mutant p53

ABHD5 as a friend or an enemy in cancer biology?

Overexpression of serum HMGB1 and IDO in esophageal squamous cell carcinoma patients: potential clinical auxiliary diagnostic markers and immunotherapeutic targets

Editorial: Theranostics as a driving force in nuclear medicine

Case report: Male genital system, soft tissue and myocardial metastases in a patient with exon 11-mutated GIST of unknown origin

Therapies targeting triple-negative breast cancer： A perspective on anti-FGFR

Radiosynthesis and in-vitro identification of a molecular probe 131I-FAPI targeting cancer-associated fibroblasts

Targeted anti-angiogenesis therapy for advanced osteosarcoma